Select a Sector or Industry
Return on Equity Rankings for Drug Manufacturers - Other Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Return on Equity
|
Pro Rating
|
|---|---|---|---|---|
| 1 | WCRX | Warner Chilcott | 633.5% | Go Pro |
| 2 | DRRX | Durect Corporation | 149.4% | Go Pro |
| 3 | POZN | Pozen | 56.39% | Go Pro |
| 4 | NVO | Novo Nordisk | 49.24% | Go Pro |
| 5 | TARO | Taro Pharmaceutical Industries | 39.16% | Go Pro |
| 6 | DUSA | DUSA Pharmaceuticals | 31.36% | Go Pro |
| 7 | UTHR | United Therapeutics Corporation | 27.31% | Go Pro |
| 8 | RDY | Dr. Reddy's Laboratories | 26.78% | Go Pro |
| 9 | SCLN | SciClone Pharmaceuticals | 25.10% | Go Pro |
| 10 | MDCO | The Medicines Company | 24.14% | Go Pro |
| 11 | PTX | Pernix Therapeutics | 22.45% | Go Pro |
| 12 | AGN | Allergan | 19.48% | Go Pro |
| 13 | FRX | Forest Laboratories | 18.07% | Go Pro |
| 14 | PCYC | Pharmacyclics | 16.47% | Go Pro |
| 15 | SCR | Simcere Pharmaceutical Group | 8.25% | Go Pro |
| 16 | CBST | Cubist Pharmaceuticals | 5.65% | Go Pro |
| 17 | ENDP | Endo Health Solutions | 2.28% | Go Pro |
| 18 | LCI | Lannett Company | 0.62% | Go Pro |
| 19 | PTIE | Pain Therapeutics | -5.54% | Go Pro |
| 20 | BIOD | Biodel | -29.13% | Go Pro |
| 21 | SCMP | Sucampo Pharmaceuticals | -30.84% | Go Pro |
| 22 | DEPO | Depomed | -32.14% | Go Pro |
| 23 | ALTH | Allos Therapeutics | -33.08% | Go Pro |
| 24 | ISIS | Isis Pharmaceuticals | -46.78% | Go Pro |
| 25 | OREX | Orexigen Therapeutics | -53.69% | Go Pro |
| 26 | NBY | NovaBay Pharmaceuticals | -58.34% | Go Pro |
| 27 | CRME | Cardiome Pharma Corporation | -73.78% | Go Pro |
| 28 | DVAX | Dynavax Technologies Corporation | -76.00% | Go Pro |
| 29 | RDEA | Ardea Biosciences | -84.24% | Go Pro |
| 30 | MAPP | MAP Pharmaceuticals | -84.97% | Go Pro |
| 31 | TELK | Telik | -100.7% | Go Pro |
| 32 | APRI | Nexmed | -224.8% | Go Pro |
| 33 | SOMX | Somaxon Pharmaceuticals | -231.5% | Go Pro |
| 34 | MSHL | Marshall Edwards | -248.5% | Go Pro |
| 35 | ALXA | Alexza Pharmaceuticals | -1246% | Go Pro |
